Literature DB >> 15175010

Kinetics of NO and O2 binding to a maleimide poly(ethylene glycol)-conjugated human haemoglobin.

Kim D Vandegriff1, Andrea Bellelli, Michele Samaja, Ashok Malavalli, Maurizio Brunori, Robert M Winslow.   

Abstract

The hypertensive effect observed with most cell-free haemoglobins has been proposed to result from NO scavenging. However, a newly developed PEG [poly(ethylene glycol)]-conjugated haemoglobin, MalPEG-Hb [maleimide-activated PEG-conjugated haemoglobin], is non-hypertensive with unique physicochemical properties: high O2 affinity, low co-operativity and large molecular radius. It is therefore of interest to compare the ligand-binding properties of MalPEG-Hb with unmodified cell-free HbA (stroma-free human haemoglobin). NO association rates for deoxy and oxyMalPEG-Hb and HbA were found to be identical. These results confirm the lack of correlation between hypertension and NO for a similar modified haemoglobin with high molecular radius and low p50 (pO2 at which haemoglobin is half-saturated with O2) [Rohlfs, Bruner, Chiu, Gonzales, Gonzales, Magde, Magde, Vandegriff and Winslow (1998) J. Biol. Chem. 273, 12128-12134]. The R-state O2 association kinetic constants were also the same for the two haemoglobins. However, even though the p50 of MalPEG-Hb is approx. half of that of HbA, the biphasic O2 dissociation rates measured at relatively high pO2 (150 Torr) were 2-fold higher, giving rise to a 2-fold lower R-state equilibrium association constant for MalPEG-Hb compared with HbA. Thus the O2 affinity of MalPEG-Hb is higher only at pO2 values lower than the intersection point of the O2 equilibrium curves for MalPEG-Hb and HbA. In summary, the present studies found similar rates of NO binding to HbA and MalPEG-Hb, eliminating the possibility that the lack of vasoactivity of MalPEG-Hb is simply the result of reduced molecular reactivity with NO. Alternatively, the unique O2-binding characteristics with low p50 and co-operativity suggest that the 'R-state' conformation of MalPEG-Hb is in a more T-state configuration and restricted from conformational change.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175010      PMCID: PMC1325971          DOI: 10.1042/BJ20040156

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Alteration of functional properties associated with the change in quaternary structure in unliganded haemoglobin.

Authors:  J V Kilmartin; J A Hewitt; J F Wootton
Journal:  J Mol Biol       Date:  1975-04-05       Impact factor: 5.469

2.  Quaternary conformational changes in human oxyhemoglobin studied by laser photolysis.

Authors:  C A Sawicki; Q H Gibson
Journal:  J Biol Chem       Date:  1977-08-25       Impact factor: 5.157

3.  A convenient spectroscopic method for the estimation of hemoglobin concentrations in cell-free solutions.

Authors:  S M Snell; M A Marini
Journal:  J Biochem Biophys Methods       Date:  1988-09

4.  Influence of globin structure on the state of the heme. I. Human deoxyhemoglobin.

Authors:  M F Perutz; J E Ladner; S R Simon; C Ho
Journal:  Biochemistry       Date:  1974-05-07       Impact factor: 3.162

5.  Influence of oxygen on perfused capillary density and capillary red cell velocity in rabbit skeletal muscle.

Authors:  L Lindbom; R F Tuma; K E Arfors
Journal:  Microvasc Res       Date:  1980-03       Impact factor: 3.514

6.  Equilibrium oxygen binding to human hemoglobin cross-linked between the alpha chains by bis(3,5-dibromosalicyl) fumarate.

Authors:  K D Vandegriff; F Medina; M A Marini; R M Winslow
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

7.  Kinetic investigations of the quaternary enhancement effect and alpha/beta differences in binding the last oxygen to hemoglobin tetramers and dimers.

Authors:  J S Philo; J W Lary
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

8.  The effects of E7 and E11 mutations on the kinetics of ligand binding to R state human hemoglobin.

Authors:  A J Mathews; R J Rohlfs; J S Olson; J Tame; J P Renaud; K Nagai
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

9.  Determination of the rate and equilibrium constants for oxygen and carbon monoxide binding to R-state human hemoglobin cross-linked between the alpha subunits at lysine 99.

Authors:  K D Vandegriff; Y C Le Tellier; R M Winslow; R J Rohlfs; J S Olson
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

Review 10.  Endothelium-derived nitric oxide: actions and properties.

Authors:  L J Ignarro
Journal:  FASEB J       Date:  1989-01       Impact factor: 5.191

View more
  9 in total

1.  Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers.

Authors:  Amy G Tsai; Pedro Cabrales; Belur N Manjula; Seetharama A Acharya; Robert M Winslow; Marcos Intaglietta
Journal:  Blood       Date:  2006-07-20       Impact factor: 22.113

2.  A bloodless revolution. A growing interest in artificial blood substitutes has resulted in new products that could soon improve transfusion medicine.

Authors:  Andrea Rinaldi
Journal:  EMBO Rep       Date:  2005-08       Impact factor: 8.807

3.  Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): dissociation between in vitro and in vivo oxidation rates.

Authors:  Kim D Vandegriff; Ashok Malavalli; Charles Minn; Eva Jiang; Jeff Lohman; Mark A Young; Michele Samaja; Robert M Winslow
Journal:  Biochem J       Date:  2006-11-01       Impact factor: 3.857

4.  Structure-function relationship in a variant hemoglobin: a combined computational-experimental approach.

Authors:  Matteo Ceccarelli; Paolo Ruggerone; Roberto Anedda; Antonella Fais; Benedetta Era; Maria Carla Sollaino; Marcella Corda; Mariano Casu
Journal:  Biophys J       Date:  2006-07-14       Impact factor: 4.033

5.  Solution structure of poly(ethylene) glycol-conjugated hemoglobin revealed by small-angle X-ray scattering: implications for a new oxygen therapeutic.

Authors:  Dmitri I Svergun; Fredrik Ekström; Kim D Vandegriff; Ashok Malavalli; Dale A Baker; Calle Nilsson; Robert M Winslow
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

6.  Targeted O2 delivery by blood substitutes: in vitro arteriolar simulations of first- and second-generation products.

Authors:  Russell Cole; Kim Vandegriff; Andrew Szeri; Omer Savas; Robert Winslow
Journal:  Microvasc Res       Date:  2008-07-11       Impact factor: 3.514

7.  CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats.

Authors:  K D Vandegriff; M A Young; J Lohman; A Bellelli; M Samaja; A Malavalli; R M Winslow
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

8.  Mathematical model of NO and O2 transport in an arteriole facilitated by hemoglobin based O2 carriers.

Authors:  Sharon Irene Gundersen; Guo Chen; Andre Francis Palmer
Journal:  Biophys Chem       Date:  2009-02-21       Impact factor: 2.352

9.  A quantitative framework for the design of acellular hemoglobins as blood substitutes: implications of dynamic flow conditions.

Authors:  Russell H Cole; Kim D Vandegriff; Andrew J Szeri; Omer Savaş; Dale A Baker; Robert M Winslow
Journal:  Biophys Chem       Date:  2007-03-13       Impact factor: 2.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.